Literature DB >> 11125118

Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs.

R Kantor1, R Machekano, M J Gonzales, K Dupnik, J M Schapiro, R W Shafer.   

Abstract

The HIV Reverse Transcriptase and Protease Sequence Database is an on-line relational database that catalogs evolutionary and drug-related sequence variation in the human immunodeficiency virus (HIV) reverse transcriptase (RT) and protease enzymes, the molecular targets of anti-HIV therapy (http://hivdb.stanford.edu). The database contains a compilation of nearly all published HIV RT and protease sequences, including submissions from International Collaboration databases and sequences published in journal articles. Sequences are linked to data about the source of the sequence sample and the antiretroviral drug treatment history of the individual from whom the isolate was obtained. During the past year 3500 sequences have been added and the data model has been expanded to include drug susceptibility data on sequenced isolates. Database content has also been integrated with didactic text and the output of two sequence analysis programs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11125118      PMCID: PMC29795          DOI: 10.1093/nar/29.1.296

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  7 in total

1.  HIV-1 nomenclature proposal.

Authors:  D L Robertson; J P Anderson; J A Bradac; J K Carr; B Foley; R K Funkhouser; F Gao; B H Hahn; M L Kalish; C Kuiken; G H Learn; T Leitner; F McCutchan; S Osmanov; M Peeters; D Pieniazek; M Salminen; P M Sharp; S Wolinsky; B Korber
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

2.  Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries.

Authors:  R W Shafer; D R Jung; B J Betts
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

3.  Human immunodeficiency virus reverse transcriptase and protease sequence database.

Authors:  R W Shafer; D R Jung; B J Betts; Y Xi; M J Gonzales
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

4.  Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.

Authors:  J M Kilby; S Hopkins; T M Venetta; B DiMassimo; G A Cloud; J Y Lee; L Alldredge; E Hunter; D Lambert; D Bolognesi; T Matthews; M R Johnson; M A Nowak; G M Shaw; M S Saag
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

Review 5.  Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.

Authors:  C C Carpenter; D A Cooper; M A Fischl; J M Gatell; B G Gazzard; S M Hammer; M S Hirsch; D M Jacobsen; D A Katzenstein; J S Montaner; D D Richman; M S Saag; M Schechter; R T Schooley; M A Thompson; S Vella; P G Yeni; P A Volberding
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

6.  Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

Authors:  M S Hirsch; F Brun-Vézinet; R T D'Aquila; S M Hammer; V A Johnson; D R Kuritzkes; C Loveday; J W Mellors; B Clotet; B Conway; L M Demeter; S Vella; D M Jacobsen; D D Richman
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

7.  Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database.

Authors:  R W Shafer; D Stevenson; B Chan
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

  7 in total
  26 in total

1.  Emerging trends of drug-resistant HIV-1 among drug-treated patients in former blood donors in Hubei, China: a three-year surveillance from 2004 to 2006.

Authors:  Jian Gong; Xiao-Qiong Wang; Xiao Tong; Xi-Hui Shen; Rong-Ge Yang
Journal:  Virol Sin       Date:  2011-12-10       Impact factor: 4.327

2.  HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.

Authors:  Rami Kantor; Lynn S Zijenah; Robert W Shafer; Solomon Mutetwa; Elizabeth Johnston; Robert Lloyd; Andrea von Lieven; Dennis Israelski; David A Katzenstein
Journal:  AIDS Res Hum Retroviruses       Date:  2002-12-10       Impact factor: 2.205

Review 3.  HIV sequence databases.

Authors:  Carla Kuiken; Bette Korber; Robert W Shafer
Journal:  AIDS Rev       Date:  2003 Jan-Mar       Impact factor: 2.500

4.  Phenotypic analysis of HIV-1 genotypic drug-resistant isolates from China, using a single-cycle system.

Authors:  Zheng Jia; Sihong Xu; Jianhui Nie; Jingyun Li; Ping Zhong; Wenbo Wang; Youchun Wang
Journal:  Mol Diagn Ther       Date:  2011-10-01       Impact factor: 4.074

5.  A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Authors:  Robert W Shafer; Kathryn Dupnik; Mark A Winters; Susan H Eshleman
Journal:  HIV Seq Compend       Date:  2001

6.  Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial.

Authors:  Duncan Smith-Rohrberg Maru; Michael J Kozal; R Douglas Bruce; Sandra A Springer; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2007-12-15       Impact factor: 3.731

7.  The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.

Authors:  Robert W Shafer; Rami Kantor; Matthew J Gonzales
Journal:  AIDS Rev       Date:  2000       Impact factor: 2.500

8.  Sequence quality analysis tool for HIV type 1 protease and reverse transcriptase.

Authors:  Allison K Delong; Mingham Wu; Diane Bennett; Neil Parkin; Zhijin Wu; Joseph W Hogan; Rami Kantor
Journal:  AIDS Res Hum Retroviruses       Date:  2011-10-26       Impact factor: 2.205

9.  Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape.

Authors:  Kristof Theys; Koen Deforche; Gertjan Beheydt; Yves Moreau; Kristel van Laethem; Philippe Lemey; Ricardo J Camacho; Soo-Yon Rhee; Robert W Shafer; Eric Van Wijngaerden; Anne-Mieke Vandamme
Journal:  BMC Bioinformatics       Date:  2010-08-03       Impact factor: 3.169

10.  Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure.

Authors:  Gustavo H Kijak; Viviana Simon; Peter Balfe; Jeroen Vanderhoeven; Sandra E Pampuro; Carlos Zala; Claudia Ochoa; Pedro Cahn; Martin Markowitz; Horacio Salomon
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.